Clinically relevant concentrations of verapamil do not enhance the sensitivity of human bone marrow CFU-GM to adriamycin and VP16 (Q43050121)
Jump to navigation
Jump to search
scientific article published on June 1, 1988
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinically relevant concentrations of verapamil do not enhance the sensitivity of human bone marrow CFU-GM to adriamycin and VP16 |
scientific article published on June 1, 1988 |
Statements
1 reference
Clinically relevant concentrations of verapamil do not enhance the sensitivity of human bone marrow CFU-GM to adriamycin and VP16 (English)
1 reference
1 reference
M. A. Smith
S. Merry
J. G. Smith
1 June 1988
1 reference
1 reference
1 reference
57
1 reference
576-578
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference